Once you begin treatment, many patients notice improvement after just one injection
For example, a head-to-head trial (SURMOUNT-5) reported 20.2% weight loss with tirzepatide vs 13.7% with semaglutide 2.4 mg over ~72 week
Zepbound is administered as a once-weekly subcutaneous injection, with dosing typically starting at 2.5 mg for 4 weeks, then increasing by 2.5 mg every 4 weeks as tolerated (through intermediate steps of 5 mg, 7.5 mg, 10 mg, 12.5 mg) to a maintenance dose of 5 mg, 10 mg, or 15 mg based on individual response and tolerability
What it is: A comprehensive, clinical-grade subcutaneous GLP-1 receptor agonist injection kit engineered for progressive weight reduction, continuous satiety enhancement, and advanced metabolic reconditioning
If theyre hurt now, they cant wait for FDA approval. But popularity shouldnt be mistaken for a prescription